Bone Therapeutics extended its collaboration with Kasios to combine ALLOB® bone cell therapy with a 3D-printed synthetic spinal fusion cage intended to support the fusion process.
Initially, preclinical studies will investigate biocompatibility of the synthetic matrix with ALLOB.
Previously, the two companies had combined Kasios’ synthetic micro-granules with ALLOB cells in preclinical studies, demonstrating that the combination resulted in increased bone formation.
Bone Therapeutics’ ALLOB is presently engaged in additional trials for spinal fusion and failed spinal fusion, as well.
Bone Therapeutics extended its collaboration with Kasios to combine ALLOB® bone cell therapy with a 3D-printed synthetic spinal fusion cage intended to support the fusion process.
Initially, preclinical studies will investigate biocompatibility of the synthetic matrix with ALLOB.
Previously, the two companies had combined...
Bone Therapeutics extended its collaboration with Kasios to combine ALLOB® bone cell therapy with a 3D-printed synthetic spinal fusion cage intended to support the fusion process.
Initially, preclinical studies will investigate biocompatibility of the synthetic matrix with ALLOB.
Previously, the two companies had combined Kasios’ synthetic micro-granules with ALLOB cells in preclinical studies, demonstrating that the combination resulted in increased bone formation.
Copy to clipboard 
